Cargando…

Development of SARS vaccines and therapeutics is still needed

Detalles Bibliográficos
Autores principales:	Jiang, Shibo, Lu, Lu, Du, Lanying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Future Medicine Ltd 2013
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7079997/ https://www.ncbi.nlm.nih.gov/pubmed/32201503 http://dx.doi.org/10.2217/fvl.12.126

Ejemplares similares

Middle East respiratory syndrome: current status and future prospects for vaccine development
por: Du, Lanying, et al.
Publicado: (2015)

The spike protein of SARS-CoV — a target for vaccine and therapeutic development
por: Du, Lanying, et al.
Publicado: (2009)

Roles of the hemagglutinin of influenza A virus in viral entry and development of antiviral therapeutics and vaccines
por: Jiang, Shibo, et al.
Publicado: (2010)

Perspective Technologies of Vaccination: Do We Still Need Old Vaccines?
por: Isaguliants, Maria, et al.
Publicado: (2022)

Receptor-binding domains of spike proteins of emerging or re-emerging viruses as targets for development of antiviral vaccines
por: Jiang, Shibo, et al.
Publicado: (2012)

Current development of COVID-19 diagnostics, vaccines and therapeutics
por: Zhang, Naru, et al.
Publicado: (2020)

From SARS-CoV to SARS-CoV-2: safety and broad-spectrum are important for coronavirus vaccine development
por: Ma, Cuiqing, et al.
Publicado: (2020)

Does the World Still Need New Covid-19 Vaccines?
por: Nohynek, Hanna, et al.
Publicado: (2022)

Current advancements and potential strategies in the development of MERS-CoV vaccines
por: Zhang, Naru, et al.
Publicado: (2014)

Learning from the past: development of safe and effective COVID-19 vaccines
por: Su, Shan, et al.
Publicado: (2020)

An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies
por: Jiang, Shibo, et al.
Publicado: (2020)

Immunotherapy of SARS based on combinations of neutralizing human monoclonal antibodies
por: Du, Lanying, et al.
Publicado: (2010)

Advances in MERS-CoV Vaccines and Therapeutics Based on the Receptor-Binding Domain
por: Zhou, Yusen, et al.
Publicado: (2019)

Recent Advances in the Development of Virus-Like Particle-Based Flavivirus Vaccines
por: Zhang, Naru, et al.
Publicado: (2020)

Receptor-binding domain-based subunit vaccines against MERS-CoV
por: Zhang, Naru, et al.
Publicado: (2015)

Effect of Low-Pathogenic Human Coronavirus-Specific Antibodies on SARS-CoV-2
por: Jiang, Shibo, et al.
Publicado: (2020)

Alzheimer's disease: Still in need of a cure!
por: EClinicalMedicine
Publicado: (2021)

Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses
por: Jiang, Shibo, et al.
Publicado: (2020)

State of the Globe: Rabies is Still Rampant and Needs Action
por: Johnson, Nicholas
Publicado: (2010)

Climate Change and Health: More Research Is Still Needed
por: Kwon, Ho-Jang
Publicado: (2020)

Why We Still Need Reliable Animal Models
por: Pechanova, Olga
Publicado: (2020)

Is Treatment for Cytopenic Myelofibrosis Still an Unmet Clinical Need?
por: Caduc, Madeline J., et al.
Publicado: (2023)

Fear of Influenza Resurgence amid COVID-19 Pandemic: Need for Effective Flu Vaccine Still Exists
por: Wijesundara, Danushka K., et al.
Publicado: (2021)

Adenovirus-based vaccines against avian-origin H5N1 influenza viruses
por: He, Biao, et al.
Publicado: (2015)

SARS Vaccine Development
por: Jiang, Shibo, et al.
Publicado: (2005)

Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses: (Trends in Immunology 41, 355–359; 2020)
por: Jiang, Shibo, et al.
Publicado: (2020)

Vaccines for the prevention against the threat of MERS-CoV
por: Du, Lanying, et al.
Publicado: (2016)

Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses
por: Wang, Ning, et al.
Publicado: (2020)

Antibodies induced by receptor-binding domain in spike protein of SARS-CoV do not cross-neutralize the novel human coronavirus hCoV-EMC
por: Du, Lanying, et al.
Publicado: (2013)

Next-generation sequencing still needs our generation's clinicians
por: Foley, A. Reghan, et al.
Publicado: (2015)

Intensive care unit stress ulcer prophylaxis: is it still needed?
por: Almadi, Majid A., et al.
Publicado: (2016)

Unbiased decision-making for acute myeloid leukemia still needed
por: Eisfeld, Ann-Kathrin
Publicado: (2022)

Middle East respiratory syndrome coronavirus (MERS-CoV): challenges in identifying its source and controlling its spread
por: Lu, Lu, et al.
Publicado: (2013)

Identification and characterization of novel neutralizing epitopes in the receptor-binding domain of SARS-CoV spike protein: Revealing the critical antigenic determinants in inactivated SARS-CoV vaccine
por: He, Yuxian, et al.
Publicado: (2006)

MERS may not be SARS; but India is still vulnerable
por: Kant, Lalit
Publicado: (2015)

Identification of SARS-CoV RBD-targeting monoclonal antibodies with cross-reactive or neutralizing activity against SARS-CoV-2
por: Tai, Wanbo, et al.
Publicado: (2020)

Why We Still Need HBV Population-Based Epidemiologic Studies
por: Adibi, Payman
Publicado: (2012)

Are clinical pharmacology studies still needed in childhood acute lymphoblastic leukemia?
por: Conter, Valentino, et al.
Publicado: (2021)

Does the “world” still need to keep live samples of the smallpox virus?
por: Muula, Adamson S
Publicado: (2022)

Mild and Moderate Hemophilia A: Neglected Conditions, Still with Unmet Needs
por: Castaman, Giancarlo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_d7lr61a49sep8fqq4loab16r0m